Damora Therapeutics Inc Stock (DMRA) Forecast
The Damora Therapeutics Inc (DMRA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $22.67, representing a +3.68% increase from the current price of $21.86. The highest analyst price target is $25.45, and the lowest is $19.88.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month DMRA Price Target
Average 20.74 (-5.12% Upside)
Is Damora Therapeutics Inc (DMRA) A Buy Now?
Oscillators
Buy: 1 · Sell: 0 · Neutral: 6Summary: Neutral
Moving Averages
Buy: 6 · Sell: 4 · Neutral: 0Summary: Buy
According to our latest analysis, DMRA could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 4 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on DMRA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 51.15 indicates that DMRA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 58.75 indicates that DMRA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 65.89 indicates that DMRA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of 17.85 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of 53.57 indicates that DMRA is still overbought but not to an extreme extent.
Long-term DMRA price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Damora Therapeutics Inc financial reports and earnings history, Damora Therapeutics Inc (DMRA) stock could reach $19.14 by 2030, $39.08 by 2040 and $81.02 by 2050. See the projected annual prices until 2050 of the Damora Therapeutics Inc stock below:
- Damora Therapeutics Inc (DMRA) is expected to reach an average price of $14.75 in 2035, with a high prediction of $16.50 and a low estimate of $4.05. This indicates an -32.55% change from the last recorded price of $21.86.
- Damora Therapeutics Inc (DMRA) stock is projected to chart a bullish course in 2040, with an average price target of $34.67, representing an +58.59% change from its current level. The forecast ranges from a conservative $25.79 to a sky-high $39.08.
- Our analysts predict Damora Therapeutics Inc (DMRA) to change +141.97% by 2045, soaring from $45.87 to an average price of $52.89, potentially reaching $58.44. While $45.87 is the low estimate, the potential upside is significant.
- Damora Therapeutics Inc (DMRA) stock is expected to climb by 2050, reaching an average of $71.87, a +228.75% change from its current level. However, a wide range of estimates exists, with high and low targets of $81.02 and $66.18, respectively, highlighting the market's uncertainty.
Damora Therapeutics Inc Stock (DMRA) Year by Year Forecast
Damora Therapeutics Inc Stock (DMRA) Price Forecast for 2026
The predicted value for Damora Therapeutics Inc (DMRA) in 2026 is set at an average of $24.64. Estimates vary from a peak of $34.89 to a trough of $13.12, indicating an +12.70% surge from the present price of $21.86.
Damora Therapeutics Inc Stock (DMRA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Damora Therapeutics Inc (DMRA) is $20.72, with a high forecast of $31.74 and a low forecast of $9.74. This indicates an -5.22% decrease from the last price of $21.86.
Damora Therapeutics Inc Stock (DMRA) Price Forecast for 2028
In 2028, Damora Therapeutics Inc (DMRA) is projected to reach an average price of $15.94, with a high projection of $28.59 and a low estimate of $6.36. This indicates an -27.08% fall from the last price of $21.86.
Damora Therapeutics Inc Stock (DMRA) Price Forecast for 2029
The 2029 price forecast for Damora Therapeutics Inc Stock (DMRA) is $12.46 on average, with a high prediction of $22.29 and a low estimate of $0.3953. This represents an -43.01% decrease from the previous price of $21.86.
Damora Therapeutics Inc Stock (DMRA) Price Forecast for 2030
Damora Therapeutics Inc Stock (DMRA) is expected to reach an average price of $8.24 in 2030, with a high forecast of $19.14 and a low forecast of $0.1375. This signifies an -62.32% decrease from the last price of $21.86.
